Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 23 , ISSUE S3 ( September, 2019 ) > List of Articles


Thrombocytopenia in Intensive Care Unit

Citation Information : Thrombocytopenia in Intensive Care Unit. Indian J Crit Care Med 2019; 23 (S3).

DOI: 10.5005/jp-journals-10071-23249

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; The Author(s).


PDF Share
  1. Crowther MA, Cook DJ, Meade MO. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care. 2005;20(4):348–353.
  2. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. July 2013;60(7):641–651.
  3. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program. 2010;2010:135–143.
  4. Andreas Greinacher, Sixten Selleng. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood 2016 128:3032-3042; doi:
  5. Drews RE. Critical issues in hematology: Anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 2003;24(4):607–622. DOI:10.1016/s0272-5231(03)00100n
  6. James N. George, M.D. Thrombotic Thrombocytopenic Purpura. N Engl J Med 2006;354:1927-1935. DOI: 10.1056/NEJMcp053024
  7. Barbara Ferrari, Alberto Maino, Luca A Lotta, Andrea Artoni, Silvia Pontiggia, Silvia M Trisolini, Alessandra Malato, Frits R Rosendaal, and Flora Peyvandi. Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study. Orphanet J Rare Dis. 2014;9:193. doi: 10.1186/s13023-014-0193-6
  8. Robert I Parker. Etiology and significance of thrombocytopenia in critically ill patients. Crit Care Clin. 2012 Jul;28(3):399-411, vi. doi: 10.1016/j.ccc.2012.04.007.
  9. Satoshi Gando, Ferhat Meziani and Marcel Levi. What's new in the diagnostic criteria of disseminated intravascular coagulation? Intensive Care Med (2016) 42:1062–1064. DOI 10.1007/s00134-016-4257-z
  10. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007 Aug 9;357(6):580-7.
  11. Tsai, H.-M. (2007). Thrombotic Thrombocytopenic Purpura: A Thrombotic Disorder Caused by ADAMTS13 Deficiency. Hematology/Oncology Clinics of North America, 21(4);609–632. doi:10.1016/j.hoc.2007.06.003
  12. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 2011;139:271–278.
  13. Jean-Louis Vincent, Pedro Castro, Beverley J. Hunt, Achim Jörres, Manuel Praga, Jose Rojas-Suarez & Eizo Watanabe. Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies—what intensivists need to know. Critical Care 2018;22:158
  14. Afshar M, and Netzer G. (2013). Update in Critical Care for the Nephrologist: Transfusion in Non hemorrhaging Critically Ill Patients. Advances in Chronic Kidney Disease, 20(1);30–38. doi:10.1053/j.ackd.2012.10.007.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.